PHARMACEUTICAL COMPOSITIONS
1,204,173. Contraceptive compositions. H. SMITH. 11 Sept., 1967, No. 11132/70. Divided out of 1,204,171. Heading A5B. Contraceptive compositions comprise 13- ethyl-17α-chloroethynyl-17#-hydroxygon- 4-en -3-one as anti-fertility agent in association with a pharmaceutically acceptable carrier (a) in a...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1,204,173. Contraceptive compositions. H. SMITH. 11 Sept., 1967, No. 11132/70. Divided out of 1,204,171. Heading A5B. Contraceptive compositions comprise 13- ethyl-17α-chloroethynyl-17#-hydroxygon- 4-en -3-one as anti-fertility agent in association with a pharmaceutically acceptable carrier (a) in an amount of from 5 to 90 micrograms formulated for daily administration and release in one day or (b) formulated as a delayed release composition for administration less frequently than daily comprising an amount of from 5 to 150 micrograms multiplied by the number of days over which it is to be released. The anti-fertility agent may be present as the racemate or d-enantiomer. The composition may be administered orally, parenterally or rectally in the form of tablets, capsules, powders, dispersible granules, cachets, solutions, suspensions, emulsions, vials, ampoules, suppositories or a delayed release composition, such as an implant, containing a plastic or a modified carboxymethyl-cellulose. |
---|